Skip to content

Transphorm, Inc.

Delisted

CIK 1715768fmd_19KK2VTZ6RTWASDVR2DA5XYFGEManufacturing · Semiconductors & Related DevicesTemplate: Standard

Coverage: Apr 01, 2017 to Dec 31, 2023, 26 periods

Income Statement · Annual · Millions · USD
Line itemFY2019FY2020FY2021FY2022FY2023
Total revenues–12112417
Cost of revenue–671317
Gross profit–5512(1)
Provision for credit losses–00––
Research and development–8679
Selling, general and administrative–9131519
Operating income(0)(12)(13)(10)(29)
Interest expense01111
Other non-operating income (expense)–1242
Income tax expense–0000
Net income(0)(15)(18)(10)(31)